Defb34 - defensin beta 34

Predicted to enable CCR2 chemokine receptor binding activity; heparin binding activity; and lipopolysaccharide binding activity. Predicted to be involved in antifungal innate immune response; defense response to Gram-negative bacterium; and defense response to Gram-positive bacterium. Predicted to act upstream of or within defense response to bacterium. Predicted to be located in microvesicle and nucleus. Predicted to be extrinsic component of membrane. Orthologous to several human genes including DEFB106B (defensin beta 106B). [provided by Alliance of Genome Resources, Apr 2022]